Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Tesaro's PARP inhibitor approved in ovarian cancer
Tesaro's PARP inhibitor approved in ovarian cancer
Tesaro's PARP inhibitor approved in ovarian cancer
Submitted by
admin
on March 27, 2017 - 10:38pm
Source:
BioPharma Dive
News Tags:
Tesaro
ovarian cancer
PARP inhibitors
niraparib
Headline:
Tesaro's PARP inhibitor approved in ovarian cancer
Do Not Allow Advertisers to Use My Personal information
